Category
The Senate’s vetting of a proposed Food and Drug Administration (FDA) commissioner may provide an opportunity for reporters to dig…

The Food and Drug Administration (FDA) announced last week a series of steps meant to address long-standing concerns about breast…

A new Joint Commission campaign encouraging people to report health care discrimination could give journalists a window into how hospitals…

The unveiling of a new federal rule last week to prevent “surprise” medical bills is worth covering on its own…

With so much focus — and rightly so — on COVID-19, it’s understandable that even the best health care journalists…

EDITOR’S NOTE: This is the second in a series about the Biden Administration’s efforts to increase COVID-19 vaccination rates among…

Is a new push by the Biden Administration to increase COVID-19 vaccinations among nursing home workers the right approach? While…

Editor’s note: This is the second of two articles on reframing the debate about low-benefit treatments. Part one published on…

It’s easy to understand the economic arguments against exposing people to medical treatments and tests that many experts say are…
